History

Like many successful biotech companies, Biotica began as a university spin-out.

Biotica was founded on the research of two Cambridge University Professors, Peter Leadlay FRS and Jim Staunton FRS. Since then it has grown through a series of collaborations into a successful drug discovery and development company.

1996           Company founded

1996           Collaboration with Pfizer on novel erythromycin analogues

1999           Collaboration with Dow AgroSciences on novel spinosads (insecticides)

2002           Venture financing from Biotechnology Value Fund (BVF) and Nordic Biotech

2005           Financing from existing investors and Ziff Asset Management

2006           Collaboration with Wyeth Pharmaceuticals on novel rapamycin analogues

2009           Collaboration with GlaxoSmithKline to discover and develop novel erythromycin macrolides